# A Study of the Efficacy and Safety of Nebivolol Added to Existing Antihypertensive Treatment in Patients With Hypertension

> **NCT00200434** · PHASE3 · COMPLETED · sponsor: **Mylan Bertek Pharmaceuticals** · enrollment: 600 (—)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Nebivolol

## Key facts

- **NCT ID:** NCT00200434
- **Lead sponsor:** Mylan Bertek Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** —
- **Final completion:** 2003-10
- **Target enrollment:** 600 (—)
- **Last updated:** 2005-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00200434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00200434, "A Study of the Efficacy and Safety of Nebivolol Added to Existing Antihypertensive Treatment in Patients With Hypertension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00200434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*